Sei Investments Co. grew its position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 24.5% in the first quarter, HoldingsChannel reports. The firm owned 67,024 shares of the company’s stock after buying an additional 13,204 shares during the quarter. Sei Investments Co.’s holdings in Molina Healthcare were worth $8,934,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Cetera Investment Advisers lifted its position in shares of Molina Healthcare by 127.4% in the first quarter. Cetera Investment Advisers now owns 9,332 shares of the company’s stock worth $1,244,000 after buying an additional 5,229 shares in the last quarter. Kopernik Global Investors LLC boosted its stake in Molina Healthcare by 132.6% during the first quarter. Kopernik Global Investors LLC now owns 291,941 shares of the company’s stock valued at $38,916,000 after buying an additional 166,407 shares during the last quarter. Alesco Advisors LLC An ESL Co purchased a new position in Molina Healthcare during the 1st quarter valued at approximately $595,000. First Trust Advisors LP grew its holdings in Molina Healthcare by 5.8% during the 1st quarter. First Trust Advisors LP now owns 160,235 shares of the company’s stock valued at $21,359,000 after buying an additional 8,719 shares in the last quarter. Finally, Westpac Banking Corp bought a new stake in Molina Healthcare in the 1st quarter worth approximately $279,000. 98.50% of the stock is owned by institutional investors.
Molina Healthcare Price Performance
NYSE:MOH opened at $196.10 on Friday. The firm has a market capitalization of $10.24 billion, a price-to-earnings ratio of -1,089.40, a PEG ratio of 28.02 and a beta of 0.74. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $244.89. The business has a 50 day simple moving average of $207.67 and a 200-day simple moving average of $177.58. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68.
Analyst Ratings Changes
MOH has been the topic of several recent research reports. Weiss Ratings cut Molina Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, July 24th. Wells Fargo & Company reduced their price target on shares of Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a research report on Tuesday, July 28th. Truist Financial decreased their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research note on Friday, July 24th. Robert W. Baird increased their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Finally, UBS Group lifted their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $202.44.
View Our Latest Stock Report on MOH
Insider Buying and Selling at Molina Healthcare
In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by insiders.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
